one step at a time….immune therapy for prostate cancer is becoming hotter!
first U.S. patients dosed in expanded... - Advanced Prostate...
first U.S. patients dosed in expanded Phase 1b clinical trial of CB307 for patients with mCRPC
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
thanks for the info as it looks promising but still in early phase with a long way to go. Let’s hope it’s effective and less toxic to current immunotherapies.
Stay strong
Not what you're looking for?
You may also like...
PHASE 3 ECLIPSE STUDY FOR (MCRPC) PATIENTS- FIRST INFUSION OF Lutetium- 177
\\"Center of Excellence in Radiopharmaceutical Therapy\\" & was accepted. Went from PSA of 1.1, at...
New Phase 1b (NON-randomized, dose timing) trial of Lu-177-PSMA-617 + Keytruda at UCSF announced
looking for a non-randomized trial in the US. This one relies on the theory that the immunotherapy...
Embark Phase 3 clinical trial
across this today ---...
Trying a high dose testosterone clinical trial
started 3-weeks ago. Here is info on the trial ( https://clinicaltrials.gov/ct2/show/NCT03734653 )....